Spots Global Cancer Trial Database for antihyperglycemic effect in type 2 diabetic patients with secondary failure to oral hypoglycemic agents
Every month we try and update this database with for antihyperglycemic effect in type 2 diabetic patients with secondary failure to oral hypoglycemic agents cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs | NCT00940251 | Antihyperglycem... | Mersina | 30 Years - 60 Years | Jyoti Clinical and Pathological Laboratory |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
